The Cost of Treating Chronic Non-Communicable Diseases: Does it Matter?
Heart disease and Type 2 diabetes mellitus are among the two leading causes of death in the CARICOM member states with HIV/AIDS a distant sixth. Attention is now being paid to non-communicable diseases which have outpaced communicable diseases as the major cause of death. This paper investigated the link between the public medical cost of treating chronic non-communicable diseases, namely heart disease and diabetes, on national output in Barbados, Guyana, Jamaica, and Trinidad and Tobago. The results provide evidence that the public medical cost of treating chronic non-communicable diseases does have a statistically significant negative impact on national output.
|Date of creation:||15 Jun 2012|
|Date of revision:||01 Oct 2012|
|Contact details of provider:|| Postal: Ludwigstraße 33, D-80539 Munich, Germany|
Web page: https://mpra.ub.uni-muenchen.de
More information through EDIRC
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Daron Acemoglu & Simon Johnson & James Robinson, 2003. "Disease and Development in Historical Perspective," Journal of the European Economic Association, MIT Press, vol. 1(2-3), pages 397-405, 04/05.
- Bloom, David E. & Canning, David & Sevilla, Jaypee, 2004. "The Effect of Health on Economic Growth: A Production Function Approach," World Development, Elsevier, vol. 32(1), pages 1-13, January.
When requesting a correction, please mention this item's handle: RePEc:pra:mprapa:42520. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Joachim Winter)
If references are entirely missing, you can add them using this form.